The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tarasov D.O.

Regional Hospital No. 3

Lebedev I.A.

Tyumen State Medical University

Seliverstov E.A.

Regional Hospital No. 3

Progressive multifocal leukoencephalopathy in HIV-positive individuals

Authors:

Tarasov D.O., Lebedev I.A., Seliverstov E.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(8): 39‑46

DOI: 10.17116/jnevro202412408139

Views: 497

Downloaded: 1

Buy for 200₽
Contact the author
Table of contents

To cite this article:

Tarasov DO, Lebedev IA, Seliverstov EA. Progressive multifocal leukoencephalopathy in HIV-positive individuals. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(8):39‑46. (In Russ.)
https://doi.org/10.17116/jnevro202412408139

Подписка 2025 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Clinical features and modern diagnostic criteria of the disease asso­ciated with myelin oligodendrocyte glycoprotein anti­body disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11):47-56
Diagnostic pote­ntial of magnetic reso­nance spectroscopy in cognitive impairment in the elde­rly. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(11):105-110
Plasma and sali­vary acetylcholinesterase acti­vity in amyotrophic late­ral scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):128-134
Anatomical predictors of classical trigeminal neuralgia. Russian Journal of Pain. 2023;(4):5-10
Non-invasive diagnosis of brain gliomas by histological type using neuroradiomics in standardized regions of inte­rest: towa­rds digi­tal biopsy. Burdenko's Journal of Neurosurgery. 2023;(6):59-66
Analysis of the need for magnetic reso­nance imaging in a multi-field hospital. Medi­cal Technologies. Asse­ssment and Choice. 2023;(4):19-25
Labo­ratory diagnostics of «key» sexually transmitted infe­ctions (literature review). Part 1. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(6):643-650
Labo­ratory diagnostics of neurosyphilis: ways of opti­mization. Part 1. «Classical» research methods. Russian Journal of Clinical Dermatology and Vene­reology. 2023;(6):652-660
Use of Atezolizumab in patients with adva­nced small cell lung cancer. P.A. Herzen Journal of Onco­logy. 2023;(6):63-67
Diagnostics of HIV-infection in the Chechen Repu­blic: current state and prospects. Russian Journal of Preventive Medi­cine. 2024;(1):17-24

The article discusses the historical aspect and modern ideas about the etiology and pathogenesis of progressive multifocal leukoencephalopathy in patients with HIV infection. An analysis and synthesis of literature data on the clinical presentation of this pathology was carried out. The possibilities and limitations of laboratory and instrumental diagnostic methods, including neuroimaging methods, are discussed in detail. The pathomorphological signs of the disease in HIV-positive individuals are covered.

Keywords:

HIV infection
progressive multifocal leukoencephalopathy
opportunistic infections
diagnosis
magnetic resonance imaging

Authors:

Tarasov D.O.

Regional Hospital No. 3

Lebedev I.A.

Tyumen State Medical University

Seliverstov E.A.

Regional Hospital No. 3

Received:

15.04.2024

Accepted:

13.05.2024

List of references:

  1. Zakharova MN. Progressive multifocal leukoencephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(9-2):29-33. (In Russ.).
  2. White MK, Sariyer IK, Gordon J, et al. Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy. Rev Med Virol. 2016;26[2]:102-114.  https://doi.org/10.1002/rmv.1866
  3. Butic AB, Spencer SA, Shaheen St. K, et al. Polyomavirus Wakes Up and Chooses Neurovirulence. Viruses. 2023;18:15(10):2112. https://doi.org/10.3390/v15102112
  4. Atkinson AL, Atwood WJ. Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions. Viruses. 2020;12(9):969.  https://doi.org/10.3390/v12090969
  5. Astrom KE, Mancall EL, Richardson EP. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain. 1958;81:93-111. 
  6. Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971;1:1257-1260.
  7. Shmidt TYe. Progressive multifocal leukoencephalopathy and other neurological manifestations of JC virus reactivation. Nevrologicheskiy Zhurnal. 2014;19(4):4-10. (In Russ.).
  8. Brynza EP. Progressive multifocal leukoencephalopathy. Molodoi Uchenyi. 2018;47(233): 205-207. (In Russ.).
  9. Belov BS. Progressive multifocal leukoencephalopathy: rheumatological aspects. Modern Rheumatology. 2015;9(3):4-9. (In Russ.).
  10. Power C, Gladden JG, Haliday W, et al. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology. 2000;54:743-746. 
  11. Vnutrennie bolezni po Tinsli R. Kharrisonu. V dvukh tomakh. Per. s angl. M.: Praktika; 2002. (In Russ.).
  12. Gustov AV, Ruina EA, Shilov DV, et al. Clinical variants of damage to the nervous system in HIV infection. Sovremennye Tekhnologii v Meditsine. 2010;3:61-65. (In Russ.).
  13. Shakhgil’dyan VI, Yadrikhinskaya MS, Safonova AP, et al. The structure of secondary diseases and modern approaches to their laboratory diagnosis in patients with HIV infection. Epidemiologiya i Infektsionnye Bolezni. Aktual’nye Voprosy. 2015;1:24-30. (In Russ.).
  14. Putilina MV, Ermoshkina NIu, Sigitov IS, et al. Progressive multifocal encephalopathy in neurological practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12):95-105. (In Russ.). https://doi.org/10.17116/jnevro201711712195-105
  15. Voznesenskiy SL, Sakhgildyan VI, Petrova EV, et al. Unspecified encephalitis in HIV-infected patients: clinical and postmortem evaluation. Terapevticheskii Arkhiv. 2021;93(11):1278-1282. (In Russ.). https://doi.org/10.26442/00403660.2021.11.201197
  16. Veksei AA, Kon’kova-Reidman AB, Smirnova NV, et al. Clinical and epidemiological aspects of progressive multifocal leukoencephalopathy in HIV infection. Zhurnal Infektologii. 2019;11(1 S1):34-35. (In Russ.).
  17. Solovei NV, Danilkovich LS, Vasilenko AI, et al. Opportunistic lesions of the nervous system in HIV-positive patients: diagnosis, differential diagnosis with CNS neoplasms and therapy. Evraziiskii Onkologicheskii Zhurnal. 2019;7(3):322-337. (In Russ.).
  18. Tsyrkunov VM. Analysis of the causes of death, the structure of secondary and concomitant pathology of HIV-infected patients in the Gomel region. Zhurnal Grodnenskogo Gosudarstvennogo Meditsinskogo Universiteta. 2019;17(5):565-577. (In Russ.). https://doi.org/10.25298/2221-8785-2019-17-5-565-577
  19. Trofimova TN, Bakulina EG, Rassokhin VV, et al. Radiation semiotics of brain lesions in HIV infection, taking into account the immune status and antiretroviral therapy. Tikhookeanskii Meditsinskii Zhurnal. 2019;3(77):60-66. (In Russ.).
  20. Samotolkina EA, Pokrovskaya AV, Matosova SV, et al. Progressive multifocal leukoencephalopathy in HIV-infected patients: clinical features and diagnosis (literature review). Journal Infectology. 2019;11(3):5-12. (In Russ.). https://doi.org/10.22625/2072-6732-2019-11-3-5-12
  21. Pokrovskaya AV, Samotolkina EA, Matosova SV, et al. Clinical and laboratory features and prognostic factors of the outcome of progressive multi-focal leukoencephalopathy in HIV-infected patients. VICh-infektsiya i Immunosupressii. 2023;15(1):50-59. (In Russ.). https://doi.org/10.22328/2077-9828-2023-15-1-50-59
  22. Konkova-Reidman AB, Mikheeva TV, Veksey AA, et al. Analysis of cases of progressive multifocal leukethephalopathy in patients with HIV infection: clinical, epidemiological, diagnostic and therapeutic aspects of the problem. HIV Infection and Immunosuppressive Disorders. 2020;12(4):81-86. (In Russ.). https://doi.org/10.22328/2077-9828-2020-12-4-81-86
  23. Sipilä JOT, Soilu-Hänninen M, Rautava P, Kytö V. Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study. J Neurol. 2019;266(2):515-521.  https://doi.org/10.1007/s00415-018-09167-y
  24. Joly M, Conte C, Cazanave C, et al. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain. 2023;146(1):349-358.  https://doi.org/10.1093/brain/awac237
  25. Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infectious Diseases. 1997;176(1):250-254. 
  26. Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26:833-854. 
  27. Lednicky J, Vilchez R, Keitel W, et al. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS. 2003;17:801-807. 
  28. Valieva DI, Puzyreva LV. Multifocal leukoencephalopathy in HIV-infected patients. Krymskii Terapevticheskii Zhurnal. 2017;2:50-54. (In Russ.).
  29. Batoroev YuK. Progressive multifocal leukoencephalopathy is a case of cytomorphological diagnosis. Novosti Klinicheskoi Tsitologii Rossii. 2022;26(2):14-17. (In Russ.). https://doi.org/10.24412/1562-4943-2022-2-0003
  30. Du Pasquier RA, Kuroda MJ, Zheng Y, et al. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain. 2004;127(9):1970-1978. https://doi.org/10.1093/brain/awh215
  31. Marzocchetti A, Tompkins T, Clifford DB, et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology. 2009;73:1551-1558. https://doi.org/10.1212/WNL.0b013e3181c0d4a1
  32. Bernal-Cano F, Joseph JT, Koralnik IJ. Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient. Journal For Neurovirology. 2007;13(5):474-476. 
  33. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60:162-173. 
  34. Bag AK, Curé JK, Chapman PR, et al. JC-virus infection of the brain. Neuroradiol. 2010;31(9):1564-1576. https://doi.org/10.3174/ajnr.A2035
  35. Jensen PN, Major EO. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neurovirol. 2001;7(4):280-287.  https://doi.org/10.1080/13550280152537102
  36. Narvid J, Rehani B, Talbott JF. Diagnostic performance of brain MRI in immune reconstitution inflammatory syndrome. J Neuroimaging. 2016;26:303-308. 
  37. Tan SK, Koralnik I. JC, BK and other polyomaviruses: Progressive multifocal leu-coencephalopathy. In: Bennet JE, Dolin R, Blaser MJ, editors. Mandel, Douglas and Bennet’s principles and practice of infectious diseases, 8th ed. New York: Saunders; 2015;1574-1589.
  38. Berger JR. The clinical features of PML. Cleve Clin J Med. 2011;78:8-12. 
  39. Lima MA, Drislane FW, Koralnik IJ. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006;24:66(2):262-264.  https://doi.org/10.1212/01.wnl.0000194227.16696.11
  40. Kartau M, Sipilä JO, Auvinen E, et al. Progressive Multifocal Leukoencephalopathy: Current Insights. Degener Neurol Neuromuscul Dis. 2019;9:109-121.  https://doi.org/10.2147/DNND.S203405
  41. Miskin DP, Herman ST, Ngo LH, et al. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016;22(4):464-471.  https://doi.org/10.1007/s13365-015-0414-3
  42. Shtul’man DR. Nevrologiya: spravochnik prakt. vracha. M.: MEDpress-inform. 2008. (In Russ.).
  43. Cortese I, Muranski P, Enose-Akahata Y, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019;380(17):597-1605. https://doi.org/10.1056/NEJMoa1815039
  44. Boster A, Hreha S, Berger J, et al. Progressive multifocal leucoencephalopathy and relapsing-remitting multiple sclerosis. Arch Neurol. 2009;66:593-599. 
  45. Artem’eva MS, Get’man KV. Dynamics and differential diagnosis of mental disorders in progressive multifocal leukoencephalopathy. Mediko-Farmatsevticheskii zhurnal «Pul’s». 2010;12(2):117. (In Russ.).
  46. Post MJ, Thurnher MM, Clifford DB, et al. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. AJNR Am J Neuroradiol. 2013;34(7):1297-1307.
  47. Wüthrich C, Dang X, Westmoreland S, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol. 2009;65(6):742-748. 
  48. Koralnik IJ, Wüthrich C, Dang X, et al. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005;57(4):576-580.  https://doi.org/10.1002/ana.20431
  49. Gheuens S, Cheeseman SH, Koralnik IJ. Hidden in plain view: emergence of Progressive Multifocal Leukoencephalopathy after treatment of CNS Toxoplasmosis. Acta neurologica Belgica. 2011;111(3):217-219. 
  50. Möhn N, Luo Y, Skripuletz T, et al. Cerebrospinal fluid analysis in 108 patients with progressive multifocal leukoencephalopathy. Fluids Barriers CNS. 2020;17:60.  https://doi.org/10.1186/s12987-020-00227-y
  51. Warnke C, Ramanujam R, Plavina T. Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry. 2013;84:1199-1205. https://doi.org/10.1136/jnnp-2012-304332
  52. Raffel J, Gafson AR, Malik O, et al. Anti-JC virus antibody titres increase over time with natalizumab treatment. Mult Scler. 2015;21(14):1833-1838. https://doi.org/10.1177/1352458515599681
  53. Schneider-Hohendorf T, Philipp K, Husstedt IW, et al. Specific loss of cellular L-selectin on CD4[+] T cells is associated with progressive multifocal leukoencephalopathy development during HIV infection. AIDS. 2014;28:793-795.  https://doi.org/10.1097/QAD.0000000000000201
  54. Lanzillo R, Liuzzi R, Vallefuoco L, et al. JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level. Ther Clin Risk Manag. 2014;10:807-814.  https://doi.org/10.2147/TCRM.S63295
  55. Otlu O, De Simone FI, Otalora YL, et al. The agnoprotein of polyomavirus JC is released by infected cells: evidence for its cellular uptake by uninfected neighboring cells. Virology. 2014;468-470:88-95.  https://doi.org/10.1016/j.virol.2014.07.054
  56. Del Valle L, Pina-Oviedo S. HIV disorders of the brain: pathology and pathogenesis. Front Biosci. 2006;11:718-732.  https://doi.org/10.2741/1830
  57. Khalili K, Safak M, Del Valle L, et al. JC virus molecular biology and the human demyelinating disease, progressive multifocal leukoencephalopathy. In: Shoshkes Reiss C., ed. Neurotropic virus infections. Cambridge University Press; Cambridge, UK; 2008;190-211. 
  58. Kuchelmeister K, Gullotta F, Bergmann M, et al. Progressive multifocal leukoencephalopathy [PML] in the acquired immunodeficiency syndrome [AIDS]. A neuropathological autopsy study of 21 cases. Pathology — Research and Practice. 1993;189(2):163-173. 
  59. Stadnyuk YuI. Demyelinating diseases. Lechenie Zabolevanii Nervnoi Sistemy. 2012;2(10):14-21. (In Russ.).
  60. Drozdov AA, Cheremisin VM, Kamyshanskaya IG, et al. The current state of the problem of differential diagnosis of structural brain lesions in AIDS patients according to MRI data. Vestnik Sankt-Peterburgskogo Universiteta. Meditsina. 2018;13(4):403-418. (In Russ.). https://doi.org/10.21638/11701/spbu11.2018.407
  61. Whiteman M, Post M, Berger J, et al. Progressive multifocal leucoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 1993;187:233-240. 
  62. Kornienko VI, Pronin IN. Diagnostic neuroradiology. M.: Publishing house «Andreeva T.M.»; 2006. (In Russ.).
  63. Berger J, Pall I, Lanska D, et al. Progressive multifocal leucoencephalopathy in patients with HIV infection. J Neurovirol. 1998;4:65-68. 
  64. Richert N, Bloomgren G, Cadavid D, et al. Imaging findings for PML in natalizumab-treated MS patients. Mult Scler. 2012;18(4):27-28. 
  65. Kulikova SN, Briukhov VV, Peresedova AV, et al. MRI-diagnosis of progressive multifocal leukoencephalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(10):95-101. (In Russ.).
  66. Zhai S, Brew BJ. Progressive multifocal leukoencephalopathy. Handb Clin Neurol. 2018;152:123-137.  https://doi.org/10.1016/B978-0-444-63849-6.00010-4

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.